Newsby HottubFor agents

Finanznachrichten.de

EQS-News: Biocons Pertuzumab erhält Marktzulassung in der EU - Erstes Biosimilar, das im Rahmen des neuen, fokussierten klinischen Ansatzes der EMA zugelassen wurde

EQS-News: Biocons Pertuzumab receives market approval in the EU - First biosimilar approved under the EMA's new, focused clinical approach

Add to CRM by Hottub

Everyone in this article who could become a relationship. Add opens CRM by Hottub's form, filled in; nothing is saved until you press Add there.